Anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease and atrial fibrillation. Experience with Idarucizumab

Anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease and atrial fibrillation. Experience with Idarucizumab

Aim. To study the characteristics of direct oral anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease (COPD) and atrial fibrillation. To show the efficacy of idarucizumab in complex therapy of severe gastrointestinal bleeding caused...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. Shpagina, O. S. Kotova, I. S. Shpagin, E. M. Loktin, A. A. Rukavitsyna, T. S. Flyagin, T. M. Smarzh, N. V. Kamneva, D. A. Gerasimenko, E. V. Anikina, A. V. Ponomareva
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2020-06-01
Series:Российский кардиологический журнал
Subjects:
direct oral anticoagulants
bleeding
idarucizumab
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3921
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items